Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs75867569 | chr5:127717273 | A/C | 3.53E-6 | 174 | 25.92 | 22.63 | 15.73 | KM Plot |
PCPG | rs7587280 | chr2:61561648 | G/A | 0.000452 | 178 | 24.1 | 30.93 | 17.85 | KM Plot |
PCPG | rs75880756 | chr7:105163821 | G/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs75903717 | chr7:33715304 | A/G | 1.24E-7 | 175 | 25.53 | 25.43 | 19.87 | KM Plot |
PCPG | rs75905172 | chr7:33711879 | G/A | 1.24E-7 | 176 | 25.4 | 25.43 | 19.87 | KM Plot |
PCPG | rs75906855 | chr2:242551845 | T/A | 4.95E-5 | 175 | 25.87 | 28.42 | 20.2 | KM Plot |
PCPG | rs7592020 | chr2:24345562 | C/G | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs7593942 | chr2:242535751 | G/A | 4.16E-5 | 177 | 25.87 | 27.27 | 20.2 | KM Plot |
PCPG | rs75947067 | chr13:27134359 | A/T | 0.000143 | 177 | 25.77 | 24.37 | 13.17 | KM Plot |
PCPG | rs7594750 | chr2:242525778 | G/A | 4.73E-5 | 176 | 25.87 | 29.95 | 19.75 | KM Plot |
PCPG | rs7594975 | chr2:6747344 | C/T | 2.53E-5 | 177 | 25.87 | 24.52 | 23.6 | KM Plot |
PCPG | rs7595268 | chr2:107245977 | C/T | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs7596933 | chr2:241527462 | G/T | 3.68E-5 | 177 | 25.97 | 20.2 | 10.3 | KM Plot |
PCPG | rs7599891 | chr2:242554912 | C/T | 4.04E-5 | 178 | 25.87 | 26.47 | 20.2 | KM Plot |
PCPG | rs7603220 | chr2:24309700 | A/G | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |